肺泡巨噬细胞是人体防御肺结核类疾病的基本保障。
The pulmonary macrophages are the body's primary defence mechanism to contain M. tuberculosis.
我们提出了肺结核分支杆菌细胞色素P 450CYP121与三氮唑类药物氟康唑的复合物的晶体结构，揭示了唑类与亚铁血红素新的结合模式。
We present here the crystal structure of Mycobacterium tuberculosis cytochrome P450 CYP121 in complex with the triazole drug fluconazole, revealing a new azole heme ligation mode.
某些罕见的遗传性疾病会造成患者对分支杆菌属极其易感，这一类细菌中的一些成员就是结核病和麻风病的病原体。
Some rare genetic diseases can make patients susceptible to infections with Mycobacterium species, the bacteria that amongst other diseases, cause tuberculosis and leprosy.
结核是世界上感染类疾病的主要死因之一。
Tuberculosis is one of the main causes of death from infectious disease in the world.
方法收集恶性胸腔积液30例、结核性胸腔积液18例、类肺炎性胸腔积液23例。
Methods The pleural effusion samples were collected from 30 patients with malignant pleural effusion, 18 patients with tuberculous pleural effusion and 23 patients with parapneumonic effusion.
方法：对肺结核患者化疗中出现类赫氏反应68例进行分析并对此反应作文献复习。
Methods: the 68 cases of pulmonary tuberculosis with the Herxheimer reaction during the course of chemotherapy for tuberculosis was analysed and the relative knowledge was studied.
方法对肺结核患者化疗中出现类赫氏反应68例进行分析并行文献复习。
Methods the 68 cases of pulmonary tuberculosis with the Herxheimer reaction during the course of chemotherapy for tuberculosis was analysed and the relative knowledge was studied.
方法：收集8个地区开始此治疗前的患者痰标本，检测用于结核病治疗的5类一线药物敏感性和耐药分子类型。
Methods. Sputum samples for testing for susceptibility to 5 first-line drugs and for molecular typing were obtained from patients starting treatment in 8 districts.
目的研究肺结核化疗期类赫氏反应的临床特征。
Objective To study the clinical features of Herxheimer-like reaction in the treatment of tuberculosis patients.
目的研究肺结核化疗期类赫氏反应的临床特征。
Objective To study the clinical features of Herxheimer-like reaction in the treatment of tuberculosis patients.
应用推荐